Maine Laws & Regulations
The information contained on this website is provided for informational purposes only and should not be construed as legal advice on any matter. The Information constitutes general information of applicable administrative regulation and/or laws related to general topics in the arena of controlled substance misuse and abuse and may not reflect current legal developments and updates. Please refer to your state legislature for any potential changes.
Menu
Maine Administrative Code (MAC)
Maine Revised Statutes Annotated (MRSA)
Maine Advertising/Marketing Information
- MRSA 22-2-5-558C §2429-B – Signs, advertising and marketing
- MRSA 22-2-5-605 §2700-A – Prohibitions
- MRSA 32-117-9 §13782 – Advertising
Maine Child Safety Information
- MAC Sec 148-201-IV – Abuse or Neglect
- MRSA 17A-2-45 § 1105-A – Aggravated trafficking of scheduled drugs
- MRSA 17A-2-45 §1105-B – Aggravated trafficking or furnishing of counterfeit drugs
- MRSA 17A-2-45 §1105-C – Aggravated furnishing of scheduled drugs
- MRSA 17A-2-45 §1105-D – Aggravated cultivating of marijuana
- MRSA 17A-2-45 §1105-E – Aggravated unlawful operation of a methamphetamine laboratory
- MRSA 22-3-3-1071 §4002 – Definitions
Maine Compounding Information
- MAC Sec 392-3-13-7 – Compounding
- MAC Sec 392-5-38-9 – Compounding
- MRSA 32-117-1 §13702-A – Definitions
- MRSA 32-117-1 §13722 – Medications, drugs, devices and other materials
- Chapter 289 – Public Law – An Act to Amend the Maine Pharmacy Act (Signed by the Gov 6/21/2021)
Maine Coroner/Medical Examiner Information
- MRSA 22 Chapter 711 – MEDICAL EXAMINER ACT §3021 – §3035
- CDC – Maine Coroner/Medical Examiner Laws
Maine Drug Checking Information (Test Strips)
- MRSA 17A-2-45 – §1111-A – Use of drug paraphernalia
- MRSA 17A-2-45 – §1111-B – Immunity from arrest, prosecution and revocation and termination proceedings when assistance has been requested for suspected drug-related overdose
- MRSA 22-2-5-558 §2383-B – Authorized possession by individuals
Maine Drug Cleanup Information (Methamphetamine & Fentanyl Labs)
- NO SPECIFIC STATE STATUTE OR INFORMATION IDENTIFIED
Maine Drug Court Information
- MRSA 4-8 §421 – Establishment
- Maine Treatment Courts – Participant Handbook (2019)
- Maine Treatment and Recovery Courts Policy and Procedure Manual (2022)
Maine Drug Free Workplace Information
- MRSA 26-7-3A: SUBSTANCE USE TESTING
- MRSA 26-7-3A §683 – Testing procedures
Maine Drugged Driving Information
- MRSA 5 Chapter 521: SUBSTANCE USE DISORDER PREVENTION, TREATMENT AND RECOVERY §20001 – §20078-A
- MRSA 29A Chapter 23: MAJOR OFFENSES – SUSPENSION AND REVOCATION §2401 – §2608
Maine Drug Violations Information
- MRSA 17A Chapter 45: DRUGS §1101 – §1126
- MRSA 22-2-5-556 §2351 – Maine Meth Watch Program
- MRSA 32 Chapter 117: MAINE PHARMACY ACT §13701 – §13849-C
Maine Electronic Prescribing Information
- MAC Section 392-4-19-3 – Additional Requirements for Specific Forms of Prescription Drug Orders
- MRSA 32-31-3 §2210 – Requirements regarding prescription of opioid medication (Nurses)
- MRSA 32-117-5 §13756 – Electronic prescribing of opioid medication (Pharmacy)
Maine First Responder Deflection Program(s) Information
- LD 1779 (HP 1142) – “An Act to Develop a Continuum of Care for Youth Involved in the Justice System and to Develop Alternatives for Juveniles Incarcerated in Long Creek Youth Development Center”
Maine 911 – Good Samaritan Information
- MRSA 17A §1111-B – Immunity from arrest, prosecution and revocation and termination proceedings when assistance has been requested for suspected drug-related overdose
- LD 1862 – An Act To Strengthen Maine’s Good Samaritan Laws Concerning Drug-related Medical Assistance
Maine Medical Marijuana, Recreational Marijuana & CBD Information
- MRSA 7 Chapter 406-A: HEMP §2231
- MRSA 22-2-5 – Chapter 558: CANNABIS, SCHEDULED DRUGS, IMITATION SCHEDULED DRUGS AND HYPODERMIC APPARATUSES §2381 – §2394
- MRSA 22-2-5 – Chapter 558-A: MARIJUANA THERAPEUTIC RESEARCH PROGRAM §2401 – §2410
- MRSA 22-2-5 – Chapter 558-B: MARIJUANA THERAPEUTIC RESEARCH PROGRAM §2411 – §2420
- MRSA 22-2-5 – Chapter 558-C: MAINE MEDICAL USE OF CANNABIS ACT §2421 – §2430-N
- MRSA TITLE 28-B: ADULT USE CANNABIS
Maine Medication Assisted Treatment (MAT) Information
- MRSA 5 Chapter 521: SUBSTANCE USE DISORDER PREVENTION, TREATMENT AND RECOVERY §20001 – §20078-A
- MRSA 24A-56A-1 §4304 – Utilization review
- MRSA 34A-3-1-2 §3052 – Comprehensive substance use disorder treatment program
Maine Naloxone Information
- MRSA 17A §1111-B – Immunity from arrest, prosecution and revocation and termination proceedings when assistance has been requested for suspected drug-related overdose
- MRSA 20A-3-223 §6307 – Possession, prescription, administration and distribution of naloxone hydrochloride or another opioid overdose-reversing medication
- MSRA 22-2-556A §2353 – Naloxone hydrochloride or another opioid overdose-reversing medication
- MRSA 32-117-9 §13792 – Sale by certain methods prohibited
Maine Needle Exchange Programs (NEP) & Syringe Services programs (SSP) Information
- MRSA 17A-2-45 §1101 – Definitions
- MRSA 17A-2-45 – §1111-A – Use of drug paraphernalia
- MRSA 17A-2-45 – §1111-B – Immunity from arrest, prosecution and revocation and termination proceedings when assistance has been requested for suspected drug-related overdose
- MRSA 22-2-5-558 §2383-B – Authorized possession by individuals
Maine Neonatal Abstinence Syndrome (NAS), Neonatal Opioid Withdrawal (NOWS) Information
- MRSA 22-3-3-1071 §4004-B – Infants born affected by substance use disorder or after prenatal exposure to drugs or with a fetal alcohol spectrum disorder
- MRSA 22-3-3-1071 §4011-B – Notification of prenatal exposure to drugs or having a fetal alcohol spectrum disorder
Maine Opioid Litigation Proceeds Information
- MRSA 5-1-9 §203-B – Funds received pursuant to court orders or other settlements of opioid crisis litigation
Maine Overdose Prevention Centers (OPC), Supervised Consumption Sites (SCS), Supervised Injection Facilities (SIF) Information
- NO SPECIFIC STATE STATUTE OR INFORMATION IDENTIFIED
Maine Overdose Surveillance/Reporting Information
- MRSA 5 §200-M – Accidental Drug Overdose Death Review Panel
Maine Pain Management Information
- MAC 14 DIV 118 – OFFICE OF SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES (SAMHS) (§§ 1 — 19)
- MAC 02-380 Ch. 21 – USE OF CONTROLLED SUBSTANCES FOR TREATMENT OF PAIN (§§ 2 — 5)
- MAC 02-373 Ch. 21 – USE OF CONTROLLED SUBSTANCES FOR TREATMENT OF PAIN (§§ 1 — 5)
- MRSA 22 §7253 – Prescribers and dispensers required to check prescription monitoring information
- MRSA 32 §2210 – Requirements regarding prescription of opioid medication
- MRSA 32 §3300-F – Requirements regarding prescription of opioid medication
- MRSA 32 §2600-C – Requirements regarding prescription of opioid medication
- MRSA 32 §3657 – Requirements regarding prescription of opioid medication
Maine Pill Press & Counterfeit Medication Information
- NO SPECIFIC STATE STATUTE OR INFORMATION IDENTIFIED
Maine Prescription Drug Drop-Off Information
- MRSA 22 Chapter 604: DISPOSAL OF UNUSED PHARMACEUTICALS §2700
- MRSA 22-1681 §8624 – Medication disposal
- MRSA 38-16 §1612 – Drug take-back stewardship program
Maine Prescription Drug Importation Information
- MRSA 5 Chapter 167: MAINE PRESCRIPTION DRUG AFFORDABILITY BOARD §2041 – §2044
- MRSA 5 Chapter 168: WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM §2045 – §2048
- SP 392 – LD 1272 – An Act to Increase Access to Low-cost Prescription drugs (Approved by Gov 6/24/2019)
Maine Prescription Drug Monitoring Program Information
- MAC 14 DIV 118 – OFFICE OF SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES (SAMHS) (§§ 1 — 19)
- MRSA 22 Chapter 1603: CONTROLLED SUBSTANCES PRESCRIPTION MONITORING §7245 – §7254
- MRSA 22 Chapter 1604: INTERSTATE PRESCRIPTION MONITORING PROGRAM COMPACT §7261 – §7274
Maine Precursor Chemicals/Including Pseudoephedrine Information
- MRSA 17A-2-45 §1105-E – Aggravated unlawful operation of a methamphetamine laboratory
- MRSA 17A -2-45 §1124 – Unlawful operation of a methamphetamine laboratory
- MRSA 22-2-5-556 §2351 – Maine Meth Watch Program
- MRSA 32 §13795 – Photographic proof of identification; discretion to sell or dispense; immunity
- MRSA 32 §13796 – Retail sale of targeted methamphetamine precursors
Maine Prison/Jail Program(s) Information
- MRSA 34A-3-1-2 §3052 – Comprehensive substance use disorder treatment program
Maine School Programs/Information
- MRSA 20A-3-223 §6307 – Possession, prescription, administration and distribution of naloxone hydrochloride or another opioid overdose-reversing medication
Maine Sober Living Homes/Recovery Residence Information
- MRSA 5 Chapter 521: SUBSTANCE USE DISORDER PREVENTION, TREATMENT AND RECOVERY §20001 – §20078-A
Maine Substance Abuse Services Information
-
MRSA 4 Chapter 8: SUBSTANCE USE DISORDER TREATMENT PROGRAMS §421 – §423
-
MRSA 4 Chapter 8-A: MENTAL HEALTH TREATMENT COURTS §431
-
MRSA 4 Chapter 8-B: VETERANS TREATMENT COURTS §433
- MRSA 5 Chapter 521: SUBSTANCE USE DISORDER PREVENTION, TREATMENT AND RECOVERY §20001 – §20078-A
- MRSA 22-4-3 Chapter 1601: ALCOHOLISM, INTOXICATION AND DRUG ABUSE PREVENTION, TREATMENT AND REHABILITATION §7101 – §7133
- MRSA 22-4-3 Chapter 1602: OFFICE OF ALCOHOLISM AND DRUG ABUSE PREVENTION §7201 – §7244
Maine Telemedicine/Telehealth Information
- MRSA 32 §3300-D – Interstate practice of telehealth
-
MRSA 32 §3300-AA – Definitions
-
MRSA 32 §3300-BB – Telehealth services permitted
-
MRSA 32 §3300-CC – Confidentiality
-
MRSA 32 §3300-DD – Professional responsibility
-
MRSA 32 §3300-EE – Rulemaking
Maine Tribal State Collaboration
- MRSA 5 Chapter 376: TRIBAL-STATE COLLABORATION §11051 – §11056
Last Update – 7/25/2024
Please report any broken links to tech@naddi.org